Intelligent Retinal Imaging Systems
IRIS offers quick and simple eye screening devices for preventative Diabetic Retinopathy care.
Founded
2011IRIS offers quick and simple eye screening devices for preventative Diabetic Retinopathy care.
Founded with the mission to eliminate preventable blindness, Intelligent Retinal Imaging Systems (IRIS) provides innovative eye screening devices designed for the early detection and prevention of Diabetic Retinopathy. The company offers a comprehensive retinal screening solution that integrates seamlessly into healthcare settings, making it as straightforward as taking a patient's blood pressure. By focusing on diabetic patients, IRIS aims to close care gaps and reduce overall healthcare costs, ultimately improving patient outcomes through early intervention.
IRIS has garnered support from notable investors and healthcare professionals who share its vision of eradicating preventable blindness. The company's technology has been widely adopted by healthcare organizations, leading to significant achievements in early detection and treatment of Diabetic Retinopathy. Through its impactful work, IRIS has made a substantial contribution to public health by helping to prevent blindness in diabetic patients, thereby enhancing the quality of life for countless individuals.
Companies similar to Intelligent Retinal Imaging Systems include Retina Technologies, Ai-Ris, Bioxytech Retina and Retina-Ai Health.
Intelligent Retinal Imaging Systems was founded in 2011.
Intelligent Retinal Imaging Systems' headquarters is located in Pensacola, FL, US.
Intelligent Retinal Imaging Systems' most recent funding round was for $4.3M (USD) in November 2019.
As of Nov 15, 2019, Intelligent Retinal Imaging Systems has raised a total of $13.3M (USD).
Intelligent Retinal Imaging Systems has 39 employees as of Feb 5, 2024.
Bioxytech Retina
bioxytech.com
